Log in
Enquire now
Magenta Therapeutics

Magenta Therapeutics

Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases.

OverviewStructured DataIssuesContributors

Contents

magentatx.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
Immunotherapy
Immunotherapy
Stem cell
Stem cell
Biomedical engineering
Biomedical engineering
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Healthcare
Healthcare
...
Location
United States
United States
Cambridge, Massachusetts
Cambridge, Massachusetts
0
B2X
B2B
B2B
CEO
Jason Gardner
Jason Gardner
0
Founder
Jason Gardner
Jason Gardner
0
Pitchbook URL
pitchbook.com/profiles...168225-04
Legal Name
Magenta Therapeutics, Inc.
Legal classification
Incorporation (business)
Incorporation (business)
Date Incorporated
2015
Number of Employees (Ranges)
51 – 2000
Number of Employees
700
Full Address
100 Technology Square 5th Floor Cambridge, MA 02139 United States0
CIK Number
1,690,5850
Place of Incorporation
Delaware
Delaware
0
Investors
Partners Innovation Fund
Partners Innovation Fund
Eventide Asset Management
Eventide Asset Management
EcoR1 Capital
EcoR1 Capital
Atlas Venture
Atlas Venture
Third Rock Ventures
Third Rock Ventures
‌
Watermill Asset Management
Casdin Capital
Casdin Capital
Google Ventures
Google Ventures
...
DUNS Number
0805308740
Founded Date
2016
0
Total Funding Amount (USD)
150,500,000
Latest Funding Round Date
April 2018
Competitors
Adicet Bio
Adicet Bio
BridgeBio
BridgeBio
Stock Symbol
MGTA0
Exchange
Nasdaq
Nasdaq
0
Glassdoor ID
2025824
Board of Directors
‌
Alison Lawton
0
Bruce Booth
Bruce Booth
0
‌
David Scadden
0
Jason Gardner
Jason Gardner
0
‌
Michael Vasconcelles
0
‌
Amy Ronneberg
0
‌
Anne McGeorge
0
‌
Jeff Albers
0
...
Latest Funding Type
Series C
Series C
NAICS Code
325,4120
CAGE Code
89EL90
Patents Assigned (Count)
13
Legal Entity Identifier
549300Z3N6ODPCOFC8900
Country
United States
United States

Other attributes

Company Operating Status
Active
Contact Page URL
magentatx.com/contact-us/
SIC Code
2,8340
Ticker Symbol
MGTA
Wikidata ID
Q99744291

Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases that is headquartered in Cambridge, Massachusetts and was founded in 2016 by Jason Gardner.

Funding
Series A

On November 16, 2016 Magenta Therapeutics completed their series A funding round with $48.5 in funding from Third Rock Ventures and Atlas Ventures.

Series B

On May 2, 2017 Magenta Therapeutics completed their series B funding round with $50 million in funding from GV (lead investor), Third Rock Ventures, Partners Innovation Fund, Casidin Capital, Atlas Ventures, and Access Industries.

Series C

On April 9, 2018 Magenta Therapeutics completed their series C funding round with $52 million in funding from Casidin Capital (lead investor), The Watermill Group, Eventide Asset Management, EcoR1 Capital, Be The Match BioTherapies, and Access Industries.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Magenta Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.